181 related articles for article (PubMed ID: 20653511)
21. Ingredients for functional drinks in neurodegenerative diseases: a review.
Zafrilla P; Morillas JM; Rubio-Perez JM; Cantos Villar E
Nat Prod Commun; 2009 May; 4(5):719-40. PubMed ID: 19445320
[TBL] [Abstract][Full Text] [Related]
22. [The role of lithium in neurodegenerative diseases: new registries for old actors].
Pérez-Martínez DA
Neurologia; 2009 Apr; 24(3):143-6. PubMed ID: 19418288
[TBL] [Abstract][Full Text] [Related]
23. Mechanical stress and formation of protein aggregates in neurodegenerative disorders.
Hachiya NS; Kozuka Y; Kaneko K
Med Hypotheses; 2008; 70(5):1034-7. PubMed ID: 17910993
[TBL] [Abstract][Full Text] [Related]
24. Beer and bread to brains and beyond: can yeast cells teach us about neurodegenerative disease?
Gitler AD
Neurosignals; 2008; 16(1):52-62. PubMed ID: 18097160
[TBL] [Abstract][Full Text] [Related]
25. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
26. Congo red and protein aggregation in neurodegenerative diseases.
Frid P; Anisimov SV; Popovic N
Brain Res Rev; 2007 Jan; 53(1):135-60. PubMed ID: 16959325
[TBL] [Abstract][Full Text] [Related]
27. A universal method for detection of amyloidogenic misfolded proteins.
Yam AY; Wang X; Gao CM; Connolly MD; Zuckermann RN; Bleu T; Hall J; Fedynyshyn JP; Allauzen S; Peretz D; Salisbury CM
Biochemistry; 2011 May; 50(20):4322-9. PubMed ID: 21539296
[TBL] [Abstract][Full Text] [Related]
28. Modulating self-assembly of amyloidogenic proteins as a therapeutic approach for neurodegenerative diseases: strategies and mechanisms.
Liu T; Bitan G
ChemMedChem; 2012 Mar; 7(3):359-74. PubMed ID: 22323134
[TBL] [Abstract][Full Text] [Related]
29. Neurodegenerative diseases linked to misfolded proteins and their therapeutic approaches: A review.
Khanam H; Ali A; Asif M; Shamsuzzaman
Eur J Med Chem; 2016 Nov; 124():1121-1141. PubMed ID: 27597727
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
31. Modulation of neurodegeneration by molecular chaperones.
Muchowski PJ; Wacker JL
Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
[TBL] [Abstract][Full Text] [Related]
32. Protein misfolding and neurodegeneration.
Soto C; Estrada LD
Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
[TBL] [Abstract][Full Text] [Related]
33. Prospects for antiapoptotic drug therapy of neurodegenerative diseases.
Waldmeier PC
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):303-21. PubMed ID: 12657369
[TBL] [Abstract][Full Text] [Related]
34. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications.
Williams A; Jahreiss L; Sarkar S; Saiki S; Menzies FM; Ravikumar B; Rubinsztein DC
Curr Top Dev Biol; 2006; 76():89-101. PubMed ID: 17118264
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of protein misfolding and aggregation by natural phenolic compounds.
Dhouafli Z; Cuanalo-Contreras K; Hayouni EA; Mays CE; Soto C; Moreno-Gonzalez I
Cell Mol Life Sci; 2018 Oct; 75(19):3521-3538. PubMed ID: 30030591
[TBL] [Abstract][Full Text] [Related]
36. Immunotherapy and naturally occurring autoantibodies in neurodegenerative disorders.
Neff F; Wei X; Nölker C; Bacher M; Du Y; Dodel R
Autoimmun Rev; 2008 Jun; 7(6):501-7. PubMed ID: 18558370
[TBL] [Abstract][Full Text] [Related]
37. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
Hol EM; Fischer DF; Ovaa H; Scheper W
Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
[TBL] [Abstract][Full Text] [Related]
38. Axonal transport defects: a common theme in neurodegenerative diseases.
Roy S; Zhang B; Lee VM; Trojanowski JQ
Acta Neuropathol; 2005 Jan; 109(1):5-13. PubMed ID: 15645263
[TBL] [Abstract][Full Text] [Related]
39. Protein misfolding and aggregation in neurodegenerative diseases: a review of pathogeneses, novel detection strategies, and potential therapeutics.
Gandhi J; Antonelli AC; Afridi A; Vatsia S; Joshi G; Romanov V; Murray IVJ; Khan SA
Rev Neurosci; 2019 May; 30(4):339-358. PubMed ID: 30742586
[TBL] [Abstract][Full Text] [Related]
40. Unique organoprotective properties of a novel IH636 grape seed proanthocyanidin extract on cadmium chloride-induced nephrotoxicity, dimethylnitrosamine (DMN)-induced splenotoxicity and mocap-induced neurotoxicity in mice.
Ray SD; Wong V; Rinkovsky A; Bagchi M; Raje RR; Bagchi D
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):105-28. PubMed ID: 11334361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
